COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECKPOINT PATHWAY INHIBITORS
作者： Oft Martin
DOI:
关键词:
摘要: The present disclosure provides a method for the treatment of neoplastic disease in mammalian subject comprising administration an IL-10 agent combination with at least one modulator immune checkpoint pathway. further wherein neoplasm has low or intermediate tumor mutation burden, level expression molecule, metastatic disease.
lens.org参考文章(52)
Muralidhara Ramachandra, Pottayil Govindan Nair Sasikumar, Immunomodulating Cyclic Compounds ,(2013)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Kristin S. Eaton, Melanie Nelson, Interleukin-10 polypeptide conjugates and their uses ,(2013)
Howard M. Shapiro, Practical Flow Cytometry ,(1985)
Sreenivas Kandepu, Rajeev K. Shrimali, Leena Khare Satyam, Koteswara Rao Vemula, Suresh Kumar Vadlamani, Muralidhara Ramachandra, Krishnaprasad Subbarao, Pottayil Govindan Nair Sasikumar, Immunosuppression modulating compounds ,(2011)
J. Milton Harris, M. R. Sedaghat-Herati, Preparation and use of polyethylene glycol propionaldehyde ,(1990)
Alexandre Ambrogelly, Brittany C. Paporello, Collette M. Cutler, Steven J. Blaisdell, Mono- and di-peg il-10 production; and uses ,(2009)
John E. Coligan, Current Protocols in Protein Science ,(1996)
Jonathan R. Kleinsasser, Dan Kleinsasser, Feeder for animals ,(1986)
Nils Lonberg, Edward L. Halk, Alan J. Korman, Yashwant M. Deo, Tibor P. Keler, Human CTLA-4 antibodies ,(2000)